Jagiellonian University
Also known as: Angiology Department, Jagiellonian University Medical College | Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College | Coronary Disease Department - Jagiellonian University medical College - Krakow (Poland) | Department of Clinical Nursery, Jagiellonian University | Department of Coronary Disease, Institute of Cardiology, Jagiellonian University Medical College | Department of Internal Medicine and Gerontology - Jagiellonian University Medical College - Krakow (Poland) | Insitute of Cardiology Jagiellonian University Krakow | Institute of Cardiology Jagiellonian University Krakow | Jagellonian University, Krakow, Poland | Jagiellonian University | Jagiellonian University 1 Dept Surgery | Jagiellonian University Colegium Medicum | Jagiellonian University College of Medicine | Jagiellonian University Medical College | Jagiellonian University Medical College Krakow - I Cardiac Department - Krakow (Poland) | KCRI | Polish-American Children's Hospital | Radoslaw Pach, MD, Ph D
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2001Last known activity
Sep 1, 2026
Timeline
1360s
- Jun 1, 1364
Jagiellonian University— Founded
Drugs by trial phase (55 distinct, 40 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
- montelukast
- irinotecan
- fluorouracil
- ivabradine
- leucovorin
- acetylsalicylic acid
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- docetaxel
- albuterol
- budesonide
- oxaliplatin
- cisplatin
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- sodium chloride
- omeprazole
- +1 more
Phase 2 (6 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Atherosclerosis
- Carcinoma
- Carcinoma, Neuroendocrine
- Communicable Diseases
- Crohn Disease
- Essential Hypertension
- Hypertension
- Infections
- Ischemia
- Osteoarthritis, Knee
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Postoperative Pain
- Spondylitis
- Spondylitis, Ankylosing
- Thyroid Diseases
- Thyroid Neoplasms
- Vascular Diseases
Recent trials (50)
- NCT07273006CollaboratorPhase 4Sep 1, 2026
- NCT06793527OfficialN/AFeb 6, 2025
- NCT06793527Sponsor investigatorN/AFeb 6, 2025
- NCT06793527Lead sponsorN/AFeb 6, 2025
- NCT06249802Sponsor investigatorPhase 4Jan 1, 2025
- NCT06249802Lead sponsorPhase 4Jan 1, 2025
- NCT06719622CollaboratorPhase 2/Phase 3Jul 30, 2024
- NCT06321861Lead sponsorN/AJan 19, 2024
- NCT06321861Sponsor investigatorN/AJan 19, 2024
- NCT06321861OfficialN/AJan 19, 2024
- NCT05700214Reponsible party - principal investigatorN/AJan 16, 2023
- NCT05700214Lead sponsorN/AJan 16, 2023
- NCT05871320Lead sponsorEarly Phase 1Dec 23, 2022
- NCT05871320Sponsor investigatorEarly Phase 1Dec 23, 2022
- NCT05871320Reponsible party - principal investigatorEarly Phase 1Dec 23, 2022
Details
- Founded
- Kraków, PL Jun 1, 1364
- Last known activity
- Sep 1, 2026